Meadowbrook Wealth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.01M |
| 2 |
Viking Therapeutics
VKTX
|
+$1.32M |
| 3 |
AbbVie
ABBV
|
+$1.15M |
| 4 |
Citigroup
C
|
+$658K |
| 5 |
Robinhood
HOOD
|
+$642K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.28M |
| 2 |
Blackstone
BX
|
+$1.1M |
| 3 |
Palantir
PLTR
|
+$1M |
| 4 |
Oracle
ORCL
|
+$854K |
| 5 |
Tesla
TSLA
|
+$809K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.42% |
| 2 | Consumer Discretionary | 14.71% |
| 3 | Healthcare | 13.6% |
| 4 | Communication Services | 13.31% |
| 5 | Financials | 11.65% |
Similar funds
Meadowbrook Wealth Management's Q4 2025 Portfolio in Review
As of Q4 2025, Meadowbrook Wealth Management held 88 positions worth $87.6M, down 8.9% from $96.2M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Meadowbrook Wealth Management withdrew a net $7.9M in Q4 2025, closing 22 positions and reducing 31 holdings. Its most notable exit was Blackstone, an estimated $1.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Meadowbrook Wealth Management opened a new position in Viking Therapeutics worth $1.31M.
- Meadowbrook Wealth Management's largest Q4 2025 buy was Viking Therapeutics: 37,205 shares worth $1.31M.
- Meadowbrook Wealth Management added most to Eli Lilly in Q4 2025, an estimated $2.01M increase.
- Meadowbrook Wealth Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.28M.
- Meadowbrook Wealth Management fully exited Blackstone in Q4 2025, selling an estimated $1.1M.
- Meadowbrook Wealth Management's ten largest holdings make up 56% of its $87.6M portfolio in Q4 2025.
- Meadowbrook Wealth Management opened 4 new positions and closed 22 in Q4 2025.
- Meadowbrook Wealth Management's portfolio value fell 8.9% quarter-over-quarter to $87.6M.
Based on Meadowbrook Wealth Management's 13F filing for Q4 2025, filed 12 Jan 2026.